BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 11147776)

  • 21. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle.
    Taylor EB; An D; Kramer HF; Yu H; Fujii NL; Roeckl KS; Bowles N; Hirshman MF; Xie J; Feener EP; Goodyear LJ
    J Biol Chem; 2008 Apr; 283(15):9787-96. PubMed ID: 18276596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.
    Iglesias MA; Furler SM; Cooney GJ; Kraegen EW; Ye JM
    Diabetes; 2004 Jul; 53(7):1649-54. PubMed ID: 15220186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
    Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
    Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro.
    Ojuka EO; Nolte LA; Holloszy JO
    J Appl Physiol (1985); 2000 Mar; 88(3):1072-5. PubMed ID: 10710405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
    Salt IP; Connell JM; Gould GW
    Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
    Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
    Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport.
    Chen HC; Bandyopadhyay G; Sajan MP; Kanoh Y; Standaert M; Farese RV; Farese RV
    J Biol Chem; 2002 Jun; 277(26):23554-62. PubMed ID: 11978788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+).
    Ojuka EO; Jones TE; Nolte LA; Chen M; Wamhoff BR; Sturek M; Holloszy JO
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1008-13. PubMed ID: 11934664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats.
    Iglesias MA; Ye JM; Frangioudakis G; Saha AK; Tomas E; Ruderman NB; Cooney GJ; Kraegen EW
    Diabetes; 2002 Oct; 51(10):2886-94. PubMed ID: 12351423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle.
    Kurth-Kraczek EJ; Hirshman MF; Goodyear LJ; Winder WW
    Diabetes; 1999 Aug; 48(8):1667-71. PubMed ID: 10426389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5'-aminoimidazole-4-carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle.
    Stephens TJ; Canny BJ; Snow RJ; McConell GK
    Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):419-23. PubMed ID: 15236627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-nonspecific reduction in skeletal muscle glucose transport in high-fat-fed rats.
    Koshinaka K; Oshida Y; Han YQ; Kubota M; Viana AY; Nagasaki M; Sato Y
    Metabolism; 2004 Jul; 53(7):912-7. PubMed ID: 15254886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute exposure to AICAR increases glucose transport in mouse EDL and soleus muscle.
    Balon TW; Jasman AP
    Biochem Biophys Res Commun; 2001 Apr; 282(4):1008-11. PubMed ID: 11352652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
    Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
    J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with the AMP-kinase activator AICAR increases glycogen storage and fatty acid oxidation in skeletal muscles but does not reduce hyperglucagonemia and hyperglycemia in insulin deficient rats.
    Vitzel KF; Bikopoulos G; Hung S; Pistor KE; Patterson JD; Curi R; Ceddia RB
    PLoS One; 2013; 8(4):e62190. PubMed ID: 23620811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electroporated GLUT4-7myc-GFP detects in vivo glucose transporter 4 translocation in skeletal muscle without discernible changes in GFP patterns.
    Knudsen JR; Henriquez-Olguin C; Li Z; Jensen TE
    Exp Physiol; 2019 May; 104(5):704-714. PubMed ID: 30710396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of GLUT4 translocation and insulin-stimulated glucose transport in transgenic mice overexpressing GLUT1 in skeletal muscle.
    Hansen PA; Wang W; Marshall BA; Holloszy JO; Mueckler M
    J Biol Chem; 1998 Jul; 273(29):18173-9. PubMed ID: 9660777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ULK1/2 and AMPK Inhibitor SBI-0206965 Blocks AICAR and Insulin-Stimulated Glucose Transport.
    Knudsen JR; Madsen AB; Persson KW; Henríquez-Olguín C; Li Z; Jensen TE
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMP-activated protein kinase: possible target for treatment of type 2 diabetes.
    Winder WW
    Diabetes Technol Ther; 2000; 2(3):441-8. PubMed ID: 11467346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake.
    Al-Khalili L; Krook A; Zierath JR; Cartee GD
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.